Inmed Pharmaceuticals Inc (INM) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inmed Pharmaceuticals Inc  (NASDAQ: INM)


Inmed Pharmaceuticals Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Inmed Pharmaceuticals Inc's ROI in the fourth quarter of 2026?
Inmed Pharmaceuticals Inc recorded a cumulative net loss of $-13 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -153.91%.

Within the Healthcare sector 668 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 3414 to 4229.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM -5.63 % 47.84 % 29.95 % 94.07 % 49.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1 7 14 12 14
Return On Investment (TTM) -153.91 % -73.35 % -65.4 % -83.48 % -91.24 %
INM's Overall Ranking # 4229 # 3414 # # #
Seq. Investment Change TTM -27.24 % -1.01 % 19.15 % 9.95 % 13.99 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -13 -9 -8 -8 -8

INM Company Profile >> Back to INM Roi Comparisons >> See Annual INM Return On Investment



Return On Investment INM's Ranking
Within: No.
Industry # 305
Sector # 669
Overall # 4229

Return On Investment Statistics
High Average Low
51.99 %
-73.24 %
-167.52 %
(Jun 30 2021)   (Jun 30 2022)







Financial Statements
Inmed Pharmaceuticals Inc's IV. Quarter Investments $ 1 Millions INM's Balance sheet
Inmed Pharmaceuticals Inc's IV. Quarter Income $ -6 Millions Quarterly INM's Income Statement
INM's Income by Division See INM's Income by Division


INM Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Mar 31 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 1 13 11 12 9
Y / Y Investment Growth -91.72 % 21.55 % -8.15 % 33.17 % 19.99 %
Net Income in Millions -13 -8 -2 -8 -19
Y / Y Net Income Growth - - - - -
Annual Return On Investment -1123.88 % -60.47 % -15.51 % -65.74 % -204.88 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INM's Competitors
Subscribers only: Roi for Inmed Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for INM's Customers

Other Ratios
INM's Roa INM's Inventory Turnover Ratio INM's Growth Rates INM's Dividend Statistics
INM's Profitability Ratios INM's Asset Turnover Ratio INM's Dividend Growth
INM's Roe INM's Valuation Ratios INM's Financial Strength Ratios INM's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-10T13:47:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.